Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology
Top Cited Papers
Open Access
- 1 September 2016
- journal article
- review article
- Published by Harborside Press, LLC in Journal of the National Comprehensive Cancer Network
- Vol. 14 (9), 1134-1163
- https://doi.org/10.6004/jnccn.2016.0122
Abstract
This selection from the NCCN Guidelines for Ovarian Cancer focuses on the less common ovarian histopathologies (LCOHs), because new algorithms were added for LCOHs and current algorithms were revised for the 2016 update. The new LCOHs algorithms include clear cell carcinomas, mucinous carcinomas, and grade 1 (low-grade) serous carcinomas/endometrioid epithelial carcinomas. The LCOHs also include carcinosarcomas (malignant mixed Müllerian tumors of the ovary), borderline epithelial tumors (also known as low malignant potential tumors), malignant sex cord-stromal tumors, and malignant germ cell tumors.This publication has 166 references indexed in Scilit:
- Ovarian Carcinosarcoma: Effects of Cytoreductive Status and Platinum-Based Chemotherapy on SurvivalObstetrics and Gynecology International, 2013
- HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseasesTumor Biology, 2011
- Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancerGynecologic Oncology, 2011
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJama-Journal Of The American Medical Association, 2010
- Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screeningGynecologic Oncology, 2010
- Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersBreast Cancer Research and Treatment, 2010
- Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009Gynecologic Oncology, 2009
- Combining a symptoms index with CA 125 to improve detection of ovarian cancerCancer, 2008
- Carcinosarcoma of the ovary treated with platinum and taxane: The memorial Sloan-Kettering Cancer Center experienceGynecologic Oncology, 2007
- Development of an ovarian cancer symptom indexCancer, 2007